Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group

Published:2019-08-27 Issue:14 Volume:8 Page:6437-6448
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hibbitts Emily¹^ORCID,Chi Yueh‐Yun¹,Hawkins Douglas S.²,Barr Frederic G.³,Bradley Julie A.⁴,Dasgupta Roshni⁵,Meyer William H.⁶,Rodeberg David A.⁷,Rudzinski Erin R.⁸,Spunt Sheri L.⁹^ORCID,Skapek Stephen X.¹⁰,Wolden Suzanne L.¹¹,Arndt Carola A. S.¹²

Affiliation:

1. Department of Biostatistics University of Florida Gainesville Florida

2. Division of Hematology/Oncology Fred Hutchinson Cancer Research Center Seattle Children's Hospital University of Washington Seattle Washington

3. Laboratory of Pathology National Cancer Institute Bethesda Maryland

4. Department of Radiation Oncology University of Florida Health Science Center Jacksonville Florida

5. Division of Pediatric General and Thoracic Surgery Cincinnati Children's Hospital Medical Center Cincinnati Ohio

6. Department of Pediatrics University of Oklahoma Health Sciences Center Oklahoma City Oklahoma

7. Department of Surgery Brody School of Medicine East Carolina University Greenville North Carolina

8. Department of Laboratories Seattle Children's Hospital Seattle Washington

9. Department of Pediatrics Stanford University School of Medicine Palo Alto California

10. Department of Hematology and Oncology UT Southwestern Medical Center Dallas Texas

11. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York City New York

12. Department of Pediatric and Adolescent Medicine Mayo Clinic Rochester Minnesota

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2504

Reference32 articles.

1. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

2. Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group

3. Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

4. Classification of Rhabdomyosarcoma and Its Molecular Basis

5. Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee;Pediatric Blood & Cancer;2024-09-03

2. A comprehensive overview of liquid biopsy applications in pediatric solid tumors;npj Precision Oncology;2024-08-03

3. Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies;Pediatric Blood & Cancer;2024-07-17

4. We need to talk—how muscle stem cells communicate;Frontiers in Cell and Developmental Biology;2024-07-10

5. Tongue orthotopic xenografts to study fusion-negative rhabdomyosarcoma invasion and metastasis in live animals;Cell Reports Methods;2024-07